Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference4%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check26 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check33 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check55 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2, and the date has changed from April 22, 2025, to April 25, 2025.SummaryDifference0.7%
Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.